12/5/2023 0 Comments Acutis diagnostics farmingdale ny"We are very proud of our outstanding research and development team who have worked tirelessly on this validation," commented Jibreel Sarij, CEO. The assay will use a standard nasopharyngeal specimen from which Acutis will extract viral RNA and then test for the presence of key genes that can be used to identify its presence. The assay will be available beginning Monday, Maand will be run under an Emergency Use Authorization granted to Acutis from the FDA. Information on services and procedures provided to Original Medicare (fee-for-service) Part B (Medical Insurance) beneficiaries by Acutis Diagnostics Inc Number of HCPCS 33 Number of Medicare Beneficiaries 38615 Number of Services 266981 Total Submitted Charge Amount 30708355.76 Total Medicare Allowed Amount 14703424.75 Total Medicare Payment Amount 14703424.75 Total Medicare Standardized Payment Amount 14418842.32 Drug Suppress Indicator Number of HCPCS Associated With Drug Services 0 Number of Medicare Beneficiaries With Drug Services 0 Number of Drug Services 0 Total Drug Submitted Charge Amount 0 Total Drug Medicare Allowed Amount 0 Total Drug Medicare Payment Amount 0 Total Drug Medicare Standardized Payment Amount 0 Medical Suppress Indicator Number of HCPCS Associated With Medical Services 33 Number of Medicare Beneficiaries With Medical 38615 Number of Medical Services 266981 Total Medical Submitted Charge Amount 30708355.76 Total Medical Medicare Allowed Amount 14703424.75 Total Medical Medicare Payment Amount 14703424.75 Total Medical Medicare Standardized Payment Amount 14418842.32 Average Age of Beneficiaries 76 Number of Beneficiaries Age LNumber of Beneficiaries Age 65 to 74 13243 Number of Beneficiaries Age 75 to 84 10382 Number of Beneficiaries Age Greater 84 10522 Number of Female Beneficiaries 24790 Number of Male Beneficiaries 13825 Number of Non-Hispanic White Beneficiaries 32013 Number of Black or African American Beneficiaries 2993 Number of Asian Pacific Islander Beneficiaries 781 Number of Hispanic Beneficiaries 1725 Number of American Indian/Alaska Native Beneficiaries 27 Number of Beneficiaries With Race Not Elsewhere Classified 1076 Number of Beneficiaries With Medicare & Medicaid Entitlement 8210 Number of Beneficiaries With Medicare Only Entitlement 30405 Percent (%) of Beneficiaries Identified With Atrial Fibrillation 0.12 Percent (%) of Beneficiaries Identified With Alzheimer’s Disease or Dementia 0.3 Percent (%) of Beneficiaries Identified With Asthma 0.08 Percent (%) of Beneficiaries Identified With Cancer 0.11 Percent (%) of Beneficiaries Identified With Heart Failure 0.21 Percent (%) of Beneficiaries Identified With Chronic Kidney Disease 0.33 Percent (%) of Beneficiaries Identified With Chronic Obstructive Pulmonary Disease 0.14 Percent (%) of Beneficiaries Identified With Depression 0.33 Percent (%) of Beneficiaries Identified With Diabetes 0.33 Percent (%) of Beneficiaries Identified With Hyperlipidemia 0.62 Percent (%) of Beneficiaries Identified With Hypertension 0.71 Percent (%) of Beneficiaries Identified With Ischemic Heart Disease 0.37 Percent (%) of Beneficiaries Identified With Osteoporosis 0.11 Percent (%) of Beneficiaries Identified With Rheumatoid Arthritis / Osteoarthritis 0.5 Percent (%) of Beneficiaries Identified With Schizophrenia / Other Psychotic Disorders 0.05 Percent (%) of Beneficiaries Identified With Stroke 0.07 Average HCC Risk Score of Beneficiaries 1.EAST NORTHPORT, N.Y., Ma/PRNewswire-PRWeb/ - Acutis Diagnostics, a clinical diagnostics laboratory headquartered in New York, announced today that it has released a multiplex laboratory test for the detection of SARS-CoV-2, the causative agent of COVID-19. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |